Isolation and characterization of a monoclonal antibody binding to the extracellular domain of the flk-2 tyrosine kinase receptor

Hybridoma. 1995 Oct;14(5):453-9. doi: 10.1089/hyb.1995.14.453.

Abstract

The flk-2 tyrosine kinase receptor is expressed on hematopoietic stem cells and on acute leukemias (AML and ALL). We have isolated a rat monoclonal antibody (71E1) that binds to this receptor with a relative affinity of 5 nM. The antibody immunoprecipitates both murine and human forms of flk-2 and can block receptor activation by its cognate ligand. In addition, 71E1 inhibits the in vitro proliferation of the murine leukemic cell line, M1, that expresses high levels of flk-2. These results suggest that 71E1 may have utility as both a reagent for elucidating the biological role of flk-2 in hematopoiesis and as an immunotherapeutic in the treatment of acute leukemias.

MeSH terms

  • 3T3 Cells
  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / isolation & purification*
  • Binding Sites, Antibody*
  • Extracellular Space / chemistry
  • Extracellular Space / immunology
  • Humans
  • Leukemia, Myeloid, Acute
  • Mice
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Proto-Oncogene Proteins / chemistry*
  • Proto-Oncogene Proteins / immunology*
  • Rats
  • Rats, Inbred Lew
  • Receptor Protein-Tyrosine Kinases / chemistry*
  • Receptor Protein-Tyrosine Kinases / immunology*
  • Tumor Cells, Cultured
  • fms-Like Tyrosine Kinase 3

Substances

  • Antibodies, Monoclonal
  • Proto-Oncogene Proteins
  • FLT3 protein, human
  • Flt3 protein, mouse
  • Receptor Protein-Tyrosine Kinases
  • fms-Like Tyrosine Kinase 3